Your browser doesn't support javascript.
loading
Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.
Quattrocchi, Emilia; Østergaard, Mikkel; Taylor, Peter C; van Vollenhoven, Ronald F; Chu, Myron; Mallett, Stephen; Perry, Hayley; Kurrasch, Regina.
Afiliação
  • Quattrocchi E; R&D Immunoinflammation, GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom.
  • Østergaard M; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen, Denmark and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Taylor PC; Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford Botnar Research Centre, Oxford, United Kingdom.
  • van Vollenhoven RF; Unit for Clinical Therapy Research, The Karolinska Institute, Stockholm, Sweden.
  • Chu M; R&D Immunoinflammation, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
  • Mallett S; Clinical Statistics, GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom.
  • Perry H; Clinical Statistics, GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom.
  • Kurrasch R; R&D Immunoinflammation, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
PLoS One ; 11(6): e0157961, 2016.
Article em En | MEDLINE | ID: mdl-27336685

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Female / Humans / Male / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article